TABLE 3.
Characteristics of Patients With and Without Subsequent MACE
| No MACE (N = 74) | MACE (N = 63) | p Value | |
|---|---|---|---|
| Age, yrs | 56 ± 12 | 56 ± 12 | 0.72 |
|
| |||
| Male | 48 (65) | 42 (67) | 0.86 |
|
| |||
| Diabetes | 13 (18) | 15 (24) | 0.40 |
|
| |||
| Hypertension | 18 (24) | 13 (21) | 0.68 |
|
| |||
| Prior myocardial infarction | 14 (19) | 14 (22) | 0.68 |
|
| |||
| Atrial fibrillation | 18 (24) | 22 (35) | 0.19 |
|
| |||
| Medications | |||
| Aspirin | 21 (28) | 19 (30) | 0.85 |
| Beta-blocker | 67 (91) | 61 (97) | 0.18 |
| ACEI/ARB | 57 (77) | 50 (79) | 0.84 |
| Spironolactone | 10 (14) | 10 (16) | 0.81 |
| Diuretic | 13 (18) | 17 (27) | 0.22 |
| Statin | 26 (35) | 18 (29) | 0.47 |
| Anticoagulant | 8 (11) | 10 (16) | 0.45 |
|
| |||
| BMI, kg/m2 | 30 ± 5 | 28 ± 8 | 0.12 |
|
| |||
| Systolic blood pressure, mm Hg | 116 ± 15 | 115 ± 18 | 0.76 |
|
| |||
| Diastolic blood pressure, mm Hg | 70 ± 11 | 70 ± 10 | 0.87 |
|
| |||
| Heart rate, beats/min | 73 ± 13 | 70 ± 12 | 0.27 |
|
| |||
| QRS duration, ms | 112 ± 32 | 114 ± 29 | 0.67 |
|
| |||
| QTc duration, ms | 446 ± 29 | 451 ± 30 | 0.31 |
|
| |||
| GFR, ml/min/1.73 m2 | 74 ± 16 | 68 ± 20 | 0.06 |
Values are mean ± SD or n (%).
MACE = major adverse cardiac events; other abbreviations as in Table 1.